KR0126674B1 - 아포빈카민산 유도체 - Google Patents

아포빈카민산 유도체

Info

Publication number
KR0126674B1
KR0126674B1 KR1019890014015A KR890014015A KR0126674B1 KR 0126674 B1 KR0126674 B1 KR 0126674B1 KR 1019890014015 A KR1019890014015 A KR 1019890014015A KR 890014015 A KR890014015 A KR 890014015A KR 0126674 B1 KR0126674 B1 KR 0126674B1
Authority
KR
South Korea
Prior art keywords
acid
apovincarnate
ether
apovincamic
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019890014015A
Other languages
English (en)
Korean (ko)
Other versions
KR900004731A (ko
Inventor
마사또시 히야시
사다까즈 요꼬모리
요시모또 나까시마
가쯔오 하따야마
Original Assignee
우에하라 아끼라
다이쇼 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우에하라 아끼라, 다이쇼 세이야꾸 가부시끼가이샤 filed Critical 우에하라 아끼라
Publication of KR900004731A publication Critical patent/KR900004731A/ko
Application granted granted Critical
Publication of KR0126674B1 publication Critical patent/KR0126674B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
KR1019890014015A 1988-09-30 1989-09-29 아포빈카민산 유도체 Expired - Fee Related KR0126674B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24688488 1988-09-30
JP63-246884 1988-09-30

Publications (2)

Publication Number Publication Date
KR900004731A KR900004731A (ko) 1990-04-12
KR0126674B1 true KR0126674B1 (ko) 1998-04-01

Family

ID=17155177

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890014015A Expired - Fee Related KR0126674B1 (ko) 1988-09-30 1989-09-29 아포빈카민산 유도체

Country Status (7)

Country Link
US (1) US4980474A (enExample)
EP (1) EP0361888B1 (enExample)
JP (1) JPH02167279A (enExample)
KR (1) KR0126674B1 (enExample)
AT (1) ATE105289T1 (enExample)
CA (1) CA1333394C (enExample)
DE (1) DE68915097T2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011765A1 (en) * 1991-12-10 1993-06-24 Taisho Pharmaceutical Co., Ltd. Novel use of (+)-2-nitroxyethyl apovincaminate
HUT72416A (en) * 1993-03-15 1996-04-29 Byk Nederland Bv Substituted alkyl-nitrates and their use to prepare pharmaceuticals for the treatment of pathologically increased intraocular pressure
DK0813411T3 (da) * 1995-02-15 2002-05-13 Takeda Chemical Industries Ltd Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein
DE112008002455T5 (de) 2007-09-20 2010-07-22 Bradley Fixtures Corp., Menomonee Falls Waschraumsystem
WO2011044247A1 (en) 2009-10-07 2011-04-14 Bradley Fixtures Corporation Lavatory system with hand dryer
US9267736B2 (en) 2011-04-18 2016-02-23 Bradley Fixtures Corporation Hand dryer with point of ingress dependent air delay and filter sensor
US9170148B2 (en) 2011-04-18 2015-10-27 Bradley Fixtures Corporation Soap dispenser having fluid level sensor
EP2828440B1 (en) 2012-03-21 2018-06-27 Bradley Fixtures Corporation Basin and hand drying system
US10100501B2 (en) 2012-08-24 2018-10-16 Bradley Fixtures Corporation Multi-purpose hand washing station
US10041236B2 (en) 2016-06-08 2018-08-07 Bradley Corporation Multi-function fixture for a lavatory system
US11015329B2 (en) 2016-06-08 2021-05-25 Bradley Corporation Lavatory drain system
CN114920743B (zh) * 2022-05-09 2023-08-04 南京中医药大学 一种吲哚生物碱及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2228479B1 (enExample) * 1973-05-07 1976-05-14 Synthelabo
IT1148733B (it) * 1980-11-14 1986-12-03 Medea Res Srl Derivati della vincamina,metodo per la sua preparazione e composizione farmaceutiche che lo contengono
HU187733B (en) * 1982-06-30 1986-02-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing apovincaminic acid derivatives
DK311683A (da) * 1982-07-26 1984-01-27 Fujisawa Pharmaceutical Co Fremgangsmaade til fremstilling af pyridylalkylnitratforbindelser
HU198207B (en) * 1985-04-19 1989-08-28 Richter Gedeon Vegyeszet Process for production of derivatives of eburnamenin and medical compositions containing them

Also Published As

Publication number Publication date
CA1333394C (en) 1994-12-06
EP0361888A2 (en) 1990-04-04
KR900004731A (ko) 1990-04-12
EP0361888A3 (en) 1991-01-02
DE68915097D1 (de) 1994-06-09
US4980474A (en) 1990-12-25
ATE105289T1 (de) 1994-05-15
JPH02167279A (ja) 1990-06-27
DE68915097T2 (de) 1994-08-25
EP0361888B1 (en) 1994-05-04
JPH0549673B2 (enExample) 1993-07-26

Similar Documents

Publication Publication Date Title
US5519038A (en) N,N'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamines
CZ292160B6 (cs) Způsob a meziprodukt pro výrobu amidu
CH387636A (fr) Procédé de préparation de nouvelles phénothiazines
US4980474A (en) Apovincaminic acid derivatives
SK10002003A3 (sk) 4-aminobenzopyránové deriváty
EP0326106B1 (en) Alkylene diamines
KR0181945B1 (ko) N,n'-비스(알콕시알킬)-피리딘-2,4-디카복실산 디아미드, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US4139533A (en) Bicyclo[2,2,1]heptane-2,3-diendo carboxylic acid imide esters of quinoline carboxylic acid
DE3724520A1 (de) Neue 3-aryl-3-cycloalkyl-piperdin-2,6-dion-derivate
US3953449A (en) 2-(4-M-CF3 or -SCF3 phenylpiperazino)-ethyl benzoates
AU568704B2 (en) Ether of n-propanolamine derivative
EP0657443A1 (en) Optically active carboxamide derivative
RU2069212C1 (ru) Производные имидазола
EP0755382A1 (en) Quinolone derivative for treatment of urinary incontinence
EP0101633B1 (en) Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
JPS6296478A (ja) 新規なイソオキサゾ−ル誘導体
JPS6136285A (ja) ニトロアポビンカミン酸誘導体、それを含有する医薬組成物、およびそれらの製法
NO151154B (no) Analogi-fremgangsmaate for fremstilling av terapeutisk aktive benzyliden-derivater
EP0702952B1 (en) Benzopyran derivatives
US4010161A (en) Piperazinoethyl-N-(2,3-dimethyl-5-oxo-1-phenyl-3Δ-pyrazolin-4-yl)carbamates
JPWO1995033726A1 (ja) ４−キノリノン誘導体又はその塩
FR2588258A1 (fr) Nouveaux derives d'amino-5 valeronitrile, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
EP0864571A1 (en) Apovincaminic acid derivative and medicine containing the same
FR2534255A1 (fr) Nouveaux derives de la 4-aroylamino piperidine, leur procede de preparation et leur application en therapeutique
JPH0314575A (ja) ２，３―ジヒドロ―１―ベンゾチエピン化合物

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20001017

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20001017

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000